UTI Healthcare Fund
Sectoral-PharmaVery HighOPEN-ENDED
- NAV as on 25 Sep 2026
- ₹342.70-0.47%1 day
- Return since launch
- 15.0%
- 52-week range
- ₹268.59 — ₹346.36
- AUM
- ₹1,444 Cr
UTI Healthcare Fund is a Sectoral-Pharma equity fund from UTI Mutual Fund with ₹1,444 Cr under management, launched in 2005. Over three years it has returned 19.1% a year, against 21.1% for its category. The expense ratio is 2.20% and the SEBI riskometer reading is Very High.
Performance
UTI Healthcare Fund NAV and returns
Growth of the fund against its category average over the period you pick.
Over 1Y this fund returned +20.2% against +19.4% for its category.
Performance
Returns
How the fund has done against its category and its benchmark.
| Period | Fund | vs category | Category | Benchmark |
|---|---|---|---|---|
| 1Y | 29.8% | +9.1 pts | 20.7% | 26.0% |
| 2Y | 18.0% | +1.2 pts | 16.8% | 15.1% |
| 3Y | 19.1% | −2.0 pts | 21.1% | 15.8% |
| 5Y | 21.1% | +6.8 pts | 14.3% | 18.1% |
| 7Y | 20.5% | +1.3 pts | 19.2% | 18.1% |
| 10Y | 18.6% | +4.9 pts | 13.7% | 16.9% |
| Period | Fund | vs category | Category | Benchmark |
|---|---|---|---|---|
| 1M | 0.2% | 0.0 pts | 0.2% | 0.2% |
| 3M | 6.2% | −0.1 pts | 6.3% | 5.9% |
| 6M | 24.5% | +2.5 pts | 22.0% | 20.9% |
| 1Y | 20.1% | −0.6 pts | 20.7% | 19.5% |
| 2Y | 9.3% | +1.0 pts | 8.2% | 6.8% |
| 3Y | 23.8% | +2.7 pts | 21.1% | 20.6% |
| 5Y | 15.1% | +0.8 pts | 14.3% | 13.3% |
| 7Y | 23.2% | +0.8 pts | 22.4% | 21.1% |
| 10Y | 13.6% | −0.1 pts | 13.7% | 12.2% |
Since launch (1 Aug 2005): 15.0%
Calendar-year returns
Category average67.4%
19.1%
-12.3%
38.2%
42.4%
-3.1%
Show as a table
| Period | Fund | vs category | Category |
|---|---|---|---|
| 2025 | -3.1% | −1.1 pts | -2.0% |
| 2024 | 42.4% | +1.6 pts | 40.9% |
| 2023 | 38.2% | +2.0 pts | 36.2% |
| 2022 | -12.3% | −4.0 pts | -8.3% |
| 2021 | 19.1% | −2.6 pts | 21.7% |
| 2020 | 67.4% | −1.4 pts | 68.8% |
Returns over one year are annualised. Shorter periods are absolute.
Costs & terms
Costs and terms
What the fund charges each year, and the rules around putting money in and taking it out.
Costs
2.21%
Expense ratio as on 23 Sep 2026
Charged yearly and already deducted from the NAV.
- Base expense
- 1.82%
- Brokerage
- 0.03%
- Transaction charges
- 0.00%
- Statutory levies
- 0.36%
- Exit load
- Exit load of 1% if redeemed within 30 days.
- Lock-in
- None
Terms
- Min SIP
- ₹3,000
- Min lumpsum
- ₹5,000
- Plan
- GROWTH
- Fund type
- OPEN-ENDED
- Benchmark
- BSE Healthcare TRI
- Short-term capital gains
- Returns taxed at 20% if you redeem before 1 year
- Long-term capital gains
- After 1 year, returns above ₹1.25 lakh in a financial year are taxed at 12.5%
Risk
Risk
What the riskometer means for this fund, and how its ratios sit against the category.
Very High
Your principal is treated as being at very high risk — typically small cap, sectoral and thematic equity schemes.
| Ratio | Fund | Category avg | Read as |
|---|---|---|---|
| Alpha | 1.22 | 0.63 | Return earned above what the benchmark alone would have given. Higher is better. |
| Beta | 0.95 | 0.93 | How hard the fund moves when the market moves. Under 1 is steadier than the market. |
| Sharpe | 1.08 | 1.04 | Return earned for each unit of total risk taken. Higher is better. |
| Sortino | 1.72 | 1.61 | Return earned for each unit of downside risk. Higher is better. |
| Std. deviation | 15.92 | 15.62 | How widely monthly returns have varied around their own average. Lower is steadier. |
| Average of 4 category peers | |||
Portfolio
UTI Healthcare Fund portfolio
Portfolio as of 31 Aug 2026
Asset allocation
- Equity94.3%
- Debt0.0%
- Other5.7%
Market cap split
- Large20.4%
- Mid36.5%
- Small43.1%
- P/E
- 42.60
- P/B
- 5.55
Top holdings
| Holding | Sector | Weight | Value | 3M chg | 6M chg | 1Y chg |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Healthcare | 8.25% | ₹119 Cr | +8.87% | +9.42% | +9.42% |
| Divi's Laboratories Ltd. | Healthcare | 6.21% | ₹89.66 Cr | +4.87% | +3.52% | +2.74% |
| Others | Others | 5.73% | ₹82.71 Cr | +11.08% | +3.57% | +1.29% |
| Ajanta Pharma Ltd. | Healthcare | 4.74% | ₹68.44 Cr | +4.70% | +7.04% | +5.38% |
| Gland Pharma Ltd. | Healthcare | 3.70% | ₹53.39 Cr | +3.98% | +3.54% | +3.33% |
| Dr. Reddy's Laboratories Ltd. | Healthcare | 3.62% | ₹52.31 Cr | +3.11% | +3.48% | +4.06% |
| Alkem Laboratories Ltd. | Healthcare | 3.29% | ₹47.43 Cr | +3.07% | +3.47% | +3.41% |
| Apollo Hospitals Enterprise Ltd. | Healthcare | 3.27% | ₹47.16 Cr | +3.56% | +3.75% | +3.61% |
| Max Healthcare Institute Ltd. | Healthcare | 3.10% | ₹44.81 Cr | +2.74% | +2.85% | +2.48% |
| Lupin Ltd. | Healthcare | 3.09% | ₹44.61 Cr | +3.80% | +5.79% | +4.57% |
| Caplin Point Laboratories Ltd. | Healthcare | 3.05% | ₹44.01 Cr | +3.08% | +2.23% | +2.81% |
| Ipca Laboratories Ltd. | Healthcare | 2.87% | ₹41.48 Cr | +2.42% | +2.17% | +1.95% |
| Global Health Ltd. | Healthcare | 2.81% | ₹40.59 Cr | +2.25% | +2.02% | +1.82% |
| Anthem Biosciences Ltd. | Healthcare | 2.62% | ₹37.81 Cr | +2.33% | +1.91% | +1.54% |
| Fortis Healthcare Ltd. | Healthcare | 2.36% | ₹34.01 Cr | +3.05% | +2.98% | +3.79% |
| Rainbow Children's Medicare Ltd. | Healthcare | 2.25% | ₹32.54 Cr | +1.64% | +0.85% | +1.06% |
| Marksans Pharma Ltd. | Healthcare | 2.23% | ₹32.16 Cr | +2.30% | +1.65% | +1.14% |
| Glenmark Pharmaceuticals Ltd. | Healthcare | 2.23% | ₹32.13 Cr | +2.42% | +4.25% | +3.78% |
| Cohance Lifesciences Ltd. | Healthcare | 2.21% | ₹31.92 Cr | +2.48% | +2.66% | +2.49% |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 2.17% | ₹31.33 Cr | +1.97% | +2.06% | +2.86% |
| Aurobindo Pharma Ltd. | Healthcare | 2.10% | ₹30.37 Cr | +1.88% | +2.66% | +2.30% |
| Procter & Gamble Health Ltd. | Healthcare | 2.00% | ₹28.84 Cr | +2.49% | +2.21% | +3.99% |
| Aster DM Quality Care Ltd. | Healthcare | 1.89% | ₹27.22 Cr | +1.94% | +1.94% | +1.64% |
| Sai Life Sciences Ltd. | Healthcare | 1.79% | ₹25.90 Cr | +2.19% | +2.07% | +1.69% |
| Dr. Lal Pathlabs Ltd. | Healthcare | 1.61% | ₹23.25 Cr | +1.32% | +1.26% | — |
| Metropolis Healthcare Ltd. | Healthcare | 1.56% | ₹22.53 Cr | +1.77% | +1.66% | +1.90% |
| Viyash Scientific Limited | Healthcare | 1.54% | ₹22.19 Cr | +2.36% | +2.11% | +1.32% |
| Cipla Ltd. | Healthcare | 1.46% | ₹21.14 Cr | +1.73% | +1.83% | +5.68% |
| Sudeep Pharma Ltd. | Healthcare | 1.42% | ₹20.56 Cr | +1.72% | +2.19% | — |
| Biocon Ltd. | Healthcare | 1.42% | ₹20.52 Cr | +0.70% | +0.70% | +1.18% |
| Vijaya Diagnostic Centre Ltd. | Healthcare | 1.39% | ₹20.09 Cr | +1.42% | +1.09% | +1.08% |
| Windlas Biotech Ltd. | Healthcare | 1.28% | ₹18.53 Cr | +1.16% | +1.13% | +1.43% |
| Eris Lifesciences Ltd. | Healthcare | 1.21% | ₹17.51 Cr | +1.55% | +1.84% | +2.88% |
| Alembic Pharmaceuticals Ltd. | Healthcare | 1.16% | ₹16.70 Cr | +1.02% | +0.52% | +0.92% |
| Manipal Health Enterprises Ltd. | Healthcare | 1.12% | ₹16.21 Cr | — | — | — |
| Pfizer Ltd. | Healthcare | 1.11% | ₹16.08 Cr | +1.35% | +1.77% | +1.74% |
| Blue Jet Healthcare Ltd. | Healthcare | 0.99% | ₹14.30 Cr | — | — | — |
| Laxmi Dental Ltd. | Healthcare | 0.98% | ₹14.22 Cr | +1.14% | +0.26% | +0.47% |
| Emcure Pharmaceuticals Ltd. | Healthcare | 0.89% | ₹12.85 Cr | +0.97% | +0.94% | +0.93% |
| Aarti Pharmalabs Ltd. | Services | 0.88% | ₹12.68 Cr | +0.78% | +0.84% | — |
| Sanofi Consumer Healthcare India Ltd. | Healthcare | 0.69% | ₹10.01 Cr | +0.91% | +0.98% | +1.11% |
| Orchid Pharma Ltd. | Healthcare | 0.68% | ₹9.85 Cr | +0.66% | +0.56% | +0.66% |
| Jubilant Pharmova Ltd. | Healthcare | 0.55% | ₹7.91 Cr | +0.73% | +0.70% | +0.82% |
| Syngene International Ltd. | Healthcare | 0.45% | ₹6.54 Cr | +0.59% | +0.69% | +1.01% |
Sectors
Instruments
Recent changes
| Holding | From | To | Weight |
|---|---|---|---|
| Others | 2.90% | 5.71% | +2.81% |
| Caplin Point Laboratories Ltd. | 3.95% | 3.05% | -0.90% |
| Krishna Institute of Medical Sciences Ltd | 0.81% | 0.00% | -0.81% |
| Divi's Laboratories Ltd. | 5.57% | 6.21% | +0.65% |
| Dr. Reddy's Laboratories Ltd. | 3.10% | 3.62% | +0.53% |
| Lupin Ltd. | 3.59% | 3.09% | -0.50% |
| Sun Pharmaceutical Industries Ltd. | 8.71% | 8.25% | -0.46% |
| Viyash Scientific Limited | 1.98% | 1.54% | -0.44% |
| Procter & Gamble Health Ltd. | 2.41% | 2.00% | -0.41% |
| Sai Life Sciences Ltd. | 2.20% | 1.79% | -0.41% |
| Max Healthcare Institute Ltd. | 2.76% | 3.10% | +0.34% |
| Sudeep Pharma Ltd. | 1.71% | 1.42% | -0.28% |
| Aurobindo Pharma Ltd. | 1.84% | 2.10% | +0.26% |
| Fortis Healthcare Ltd. | 2.58% | 2.36% | -0.23% |
| Manipal Health Enterprises Ltd. | 0.91% | 1.12% | +0.21% |
| Apollo Hospitals Enterprise Ltd. | 3.46% | 3.27% | -0.20% |
| Ipca Laboratories Ltd. | 2.68% | 2.87% | +0.20% |
| Alkem Laboratories Ltd. | 3.10% | 3.29% | +0.19% |
| Aarti Pharmalabs Ltd. | 0.73% | 0.88% | +0.15% |
| Cipla Ltd. | 1.61% | 1.46% | -0.15% |
| Gland Pharma Ltd. | 3.56% | 3.70% | +0.14% |
| Blue Jet Healthcare Ltd. | 1.13% | 0.99% | -0.14% |
| Biocon Ltd. | 1.55% | 1.42% | -0.13% |
| Eris Lifesciences Ltd. | 1.33% | 1.21% | -0.12% |
| Anthem Biosciences Ltd. | 2.50% | 2.62% | +0.12% |
| Sanofi Consumer Healthcare India Ltd. | 0.81% | 0.69% | -0.12% |
| Windlas Biotech Ltd. | 1.17% | 1.28% | +0.12% |
| Glenmark Pharmaceuticals Ltd. | 2.11% | 2.23% | +0.11% |
| Emcure Pharmaceuticals Ltd. | 0.99% | 0.89% | -0.10% |
| Vijaya Diagnostic Centre Ltd. | 1.30% | 1.39% | +0.09% |
| Pfizer Ltd. | 1.21% | 1.11% | -0.09% |
| Metropolis Healthcare Ltd. | 1.64% | 1.56% | -0.08% |
| Rainbow Children's Medicare Ltd. | 2.34% | 2.25% | -0.08% |
| Jubilant Pharmova Ltd. | 0.61% | 0.55% | -0.06% |
| Ajanta Pharma Ltd. | 4.80% | 4.74% | -0.06% |
| Marksans Pharma Ltd. | 2.17% | 2.23% | +0.06% |
| Dr. Lal Pathlabs Ltd. | 1.67% | 1.61% | -0.06% |
| Aster DM Quality Care Ltd. | 1.94% | 1.89% | -0.06% |
| Orchid Pharma Ltd. | 0.73% | 0.68% | -0.05% |
| Cohance Lifesciences Ltd. | 2.17% | 2.21% | +0.04% |
| Laxmi Dental Ltd. | 1.02% | 0.98% | -0.04% |
| Jupiter Life Line Hospitals Ltd. | 2.18% | 2.17% | -0.01% |
| Syngene International Ltd. | 0.46% | 0.45% | -0.01% |
| Alembic Pharmaceuticals Ltd. | 1.16% | 1.16% | -0.01% |
| Global Health Ltd. | 2.81% | 2.81% | 0.00% |
Compare
Similar funds
The rest of the category, so this fund’s numbers have something to sit against.
| Fund | AUM | Expense | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| Category average | ₹4,113 Cr | 2.19% | 26.1% | 17.4% | 19.9% |
 ICICI Prudential Healthcare Fund | ₹6,996 Cr | 2.07% | 14.0% | 14.2% | 19.5% |
 SBI Healthcare Opportunities Fund | ₹5,796 Cr | 1.99% | 32.5% | 19.9% | 22.3% |
 Mirae Asset Healthcare Fund | ₹3,555 Cr | 2.03% | 29.6% | 18.5% | 19.8% |
 LIC MF Healthcare Fund | ₹103 Cr | 2.67% | 28.3% | 16.9% | 17.9% |
About
About this fund
The scheme’s own words, its benchmark and the people running it.
Investment objective
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
Fund managers
- Kamal GadaMr. Gada is B.com, CA, CS, & CFAPrior to joining UTI Mutual Fund he has worked with BPCL as Senior Accounts Officer.
Tools
Return calculator
What ₹10,000 a month in this fund would have grown to over each period, based on its past returns.
₹
| Over the past | Total investment | Would’ve become | Growth | Returns |
|---|---|---|---|---|
| 6 months24.53% absolute | ₹60,000 | ₹74,718 | 24.53% | |
| 1 year20.15% annualised | ₹1,20,000 | ₹1,33,939 | 11.62% | |
| 3 years23.81% annualised | ₹3,60,000 | ₹5,28,648 | 46.85% | |
| 5 years15.13% annualised | ₹6,00,000 | ₹9,00,105 | 50.02% |
Returns for 1 year and longer are annualised (CAGR); 6-month figures are absolute. Past returns are not a forecast.
How this is calculated
Each monthly instalment grows at the fund’s annualised return ÷ 12 per month until the end of the period, the same formula as our SIP calculator.
The amount compounds once a year at the fund’s CAGR for that period, the same formula as our lumpsum calculator.
Questions
Frequently asked questions
The things people ask about this scheme.
What is the NAV of UTI Healthcare Fund?
The NAV of UTI Healthcare Fund is ₹342.70 as on 25 Sep 2026.
What is the expense ratio of UTI Healthcare Fund?
The expense ratio of UTI Healthcare Fund is 2.20% per year.
What is the minimum SIP amount for UTI Healthcare Fund?
You can start a SIP in UTI Healthcare Fund with ₹3,000 a month.
What returns has UTI Healthcare Fund given?
UTI Healthcare Fund has returned 29.8% over 1 year, 19.1% over 3 years and 21.1% over 5 years (annualised).
Is there a lock-in or exit load on UTI Healthcare Fund?
Lock-in: None. Exit load: Exit load of 1% if redeemed within 30 days..
How risky is UTI Healthcare Fund?
UTI Healthcare Fund is rated Very High on the SEBI riskometer and belongs to the Sectoral-Pharma category.
Which fund house manages UTI Healthcare Fund?
UTI Healthcare Fund is managed by UTI Mutual Fund, which runs 66 schemes with ₹3,94,848 Cr under management.